Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model

[1]  John H. Zhang,et al.  Recombinant Slit2 Reduces Surgical Brain Injury Induced Blood Brain Barrier Disruption via Robo4 Dependent Rac1 Activation in a Rodent Model , 2017, Scientific Reports.

[2]  Pedro M. Borralho,et al.  The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target. , 2016, Drug discovery today.

[3]  Shu Liu,et al.  Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury. , 2016, Biomaterials.

[4]  John H. Zhang,et al.  Recombinant Slit2 attenuates neuroinflammation after surgical brain injury by inhibiting peripheral immune cell infiltration via Robo1-srGAP1 pathway in a rat model , 2016, Neurobiology of Disease.

[5]  M. Zigmond,et al.  ERK1, 2, and 5 expression and activation in dopaminergic brain regions during postnatal development , 2015, International Journal of Developmental Neuroscience.

[6]  A. Harvey,et al.  Neurotrophic factors for spinal cord repair: Which, where, how and when to apply, and for what period of time? , 2015, Brain Research.

[7]  D. Storm,et al.  Inducible Activation of ERK5 MAP Kinase Enhances Adult Neurogenesis in the Olfactory Bulb and Improves Olfactory Function , 2015, The Journal of Neuroscience.

[8]  N. Tran,et al.  Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells* , 2014, The Journal of Biological Chemistry.

[9]  Wei Tang,et al.  Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases , 2014, BioMed research international.

[10]  M. Zigmond,et al.  The role of ERK1, 2, and 5 in dopamine neuron survival during aging , 2014, Neurobiology of Aging.

[11]  M. Bothwell.  NGF, BDNF, NT3, and NT4. , 2014, Handbook of experimental pharmacology.

[12]  John H. Zhang,et al.  P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH , 2013, Neurobiology of Disease.

[13]  K. Bath,et al.  BDNF control of adult SVZ neurogenesis. , 2012, Developmental psychobiology.

[14]  T. Kitazono,et al.  Neurotrophin production in brain pericytes during hypoxia: a role of pericytes for neuroprotection. , 2012, Microvascular research.

[15]  Jonathan A. Cooper,et al.  Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex , 2011, Nature Neuroscience.

[16]  John H. Zhang,et al.  Mechanisms of Osteopontin-Induced Stabilization of Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Rats , 2010, Stroke.

[17]  R. Doebele,et al.  A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. , 2009, Blood.

[18]  R. Sindwani,et al.  Advances in absorbable biomaterials and nasal packing. , 2009, Otolaryngologic clinics of North America.

[19]  D. Brann,et al.  The ERK5–MEF2C transcription factor pathway contributes to anti-apoptotic effect of cerebral ischemia preconditioning in the hippocampal CA1 region of rats , 2009, Brain Research.

[20]  P. Grieb,et al.  Apoptotic death of cortical neurons following surgical brain injury. , 2008, Folia neuropathologica.

[21]  S. Mowla,et al.  Gene expression alterations of neurotrophins, their receptors and prohormone convertases in a rat model of spinal cord contusion , 2008, Neuroscience Letters.

[22]  John H. Zhang,et al.  Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents , 2008, Brain Research.

[23]  John H. Zhang,et al.  Surgical brain injury: prevention is better than cure. , 2008, Frontiers in bioscience : a journal and virtual library.

[24]  Hari Shanker Sharma,et al.  A Select Combination of Neurotrophins Enhances Neuroprotection and Functional Recovery following Spinal Cord Injury , 2007, Annals of the New York Academy of Sciences.

[25]  J. Golzarian,et al.  Gelatine sponge particles: handling characteristics for endovascular use. , 2007, Techniques in vascular and interventional radiology.

[26]  A. Obenaus,et al.  MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY‐INDUCED BRAIN INJURY , 2007, Neurosurgery.

[27]  K. Aoki,et al.  Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth , 2007, The Journal of cell biology.

[28]  A. Obenaus,et al.  Neuroprotection against surgically induced brain injury. , 2007, Surgical neurology.

[29]  Feng Yang,et al.  Neurotrophin 3 induces structural and functional modification of synapses through distinct molecular mechanisms , 2006, The Journal of cell biology.

[30]  B. Su,et al.  Brain-derived Neurotrophic Factor Activates ERK5 in Cortical Neurons via a Rap1-MEKK2 Signaling Cascade* , 2006, Journal of Biological Chemistry.

[31]  Satoko Nishimoto,et al.  MAPK signalling: ERK5 versus ERK1/2 , 2006, EMBO reports.

[32]  J. Häggblad,et al.  Platelet-Derived Growth Factor (PDGF-BB) and Brain-Derived Neurotrophic Factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions , 2005, Neuroscience.

[33]  E. Nishida,et al.  Requirement of the MEK5–ERK5 pathway for neural differentiation in Xenopus embryonic development , 2005, EMBO reports.

[34]  S. Pomeroy,et al.  A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. , 2005, Cancer research.

[35]  Tsong-Hai Lee,et al.  Dexamethasone enhances NT-3 expression in rat hippocampus after traumatic brain injury , 2005, Experimental Neurology.

[36]  S. Finklestein,et al.  Growth factor treatment of stroke. , 2005, Current drug targets. CNS and neurological disorders.

[37]  B. Berk,et al.  Big Mitogen-Activated Protein Kinase (BMK1)/ERK5 Protects Endothelial Cells From Apoptosis , 2004, Circulation research.

[38]  P. Lazarovici,et al.  Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. , 2004, Progress in brain research.

[39]  U. Felderhoff‐Mueser,et al.  Pathways Leading to Apoptotic Neurodegeneration Following Trauma to the Developing Rat Brain , 2002, Neurobiology of Disease.

[40]  Rosalind A. Segal,et al.  Neurotrophins use the Erk5 pathway to mediate a retrograde survival response , 2001, Nature Neuroscience.

[41]  R. Hicks,et al.  Mild Experimental Brain Injury Differentially Alters the Expression of Neurotrophin and Neurotrophin Receptor mRNAs in the Hippocampus , 1999, Experimental Neurology.

[42]  H. Nagasaki,et al.  Topical application of neurotrophin-3 attenuates ischemic brain injury after transient middle cerebral artery occlusion in rats , 1999, Brain Research.

[43]  J. Alberch,et al.  The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum. , 1999, Brain research. Molecular brain research.

[44]  E. Mccleskey,et al.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.

[45]  L. Arsenault,et al.  The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  N. Belluardo,et al.  Increased expression of trkB and trkC messenger RNAS in the rat forebrain after focal mechanical injury , 1993, Neuroscience.

[47]  P. Ernfors,et al.  Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system , 1992, Neuroscience.